Twist Bioscience Corporation announced it will issue up to 632,328 shares of its common stock in a private placement to certain investors. This includes up to 324,558 shares and $5 million in cash to Invenra Inc. for a license agreement and technology transfer, and up to 307,770 shares to Invenra investors for an approximate 6% ownership stake in Invenra. The transactions were conducted in reliance on an exemption from registration under the Securities Act.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-015730), on February 17, 2026, and is solely responsible for the information contained therein.